{"retracted":false,"update":{"timestamp":1420675200000,"doi":"10.1007/s11102-014-0628-z","type":"correction"},"doi":"10.1007/s11102-014-0585-6","journal":"Pituitary","publisher":"Springer Nature","title":"Erratum to: Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25Â months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study"}
